Next-Generation Multi-Frequency Harmonic Acoustography for Advanced Tissue Analysis

A paradigm-shifting approach to multi-frequency harmonic acoustography, enabling unprecedented tissue penetration, real-time analysis, and personalized health insights through the integration of adaptive frequency hopping, machine learning, micro-robotics, and wearable devices.

The original patent disclosed a method for multi-frequency harmonic acoustography for target identification and border detection. However, it has limitations in terms of tissue penetration, noise reduction, and real-time analysis. The new inventive concept addresses these limitations by introducing advanced technologies that enable enhanced tissue penetration, reduced noise, and real-time tissue classification and anomaly detection.

The next-generation multi-frequency harmonic acoustography system comprises a transducer array with adaptive frequency hopping, allowing for optimized tissue penetration and reduced noise. A machine learning module enables real-time tissue classification and anomaly detection. Additionally, a swarm of micro-robots, each equipped with a miniaturized transducer, can be used for high-resolution imaging and real-time monitoring of tissue dynamics. The system can also be integrated with wearable devices and cloud-based analytics platforms for personalized health insights.

The new inventive concept introduces several novel and non-obvious features, including adaptive frequency hopping, machine learning-based tissue classification, micro-robotics for high-resolution imaging, and wearable devices for continuous health monitoring. These advancements significantly improve the capabilities of multi-frequency harmonic acoustography and enable new applications in cancer diagnosis, personalized health monitoring, and real-time tissue analysis.

Alternative embodiments of the inventive concept may include the use of different types of transducers, such as capacitive micromachined ultrasonic transducers (CMUTs) or piezoelectric micromachined ultrasonic transducers (PMUTs). Additionally, the system could be adapted for use in various medical specialties, such as cardiology or neurology, or for industrial applications, such as non-destructive testing.

The next-generation multi-frequency harmonic acoustography system has significant commercial potential in the medical device industry, particularly in the areas of cancer diagnosis, personalized health monitoring, and real-time tissue analysis. The market for medical imaging and diagnostics is expected to grow significantly in the coming years, driven by advances in technology and increasing demand for non-invasive and minimally invasive diagnostic tools.